Pfizer has announced a voluntarily recall involving 14 lots of the oral contraceptive Lo/Ovral-28 and 14 lots of generic norgestrel and ethinyl estradiol tablets, due to packaging defects that could result in unintended pregnancy.
The manufacturer reports that blister packs containing the oral contraceptives could have inexact numbers of inert or active ingredients, or may be out of sequential order.
“These packaging defects do not pose any immediate health risks. However, consumers exposed to affected packaging should begin using a non-hormonal form of contraception immediately,” Pfizer said in a press release.
The company is advising those in possession of the products to contact their healthcare provider, and return the pills to their pharmacist. A full list of the affected packs, which contain 21 tablets of active ingredients and seven tablets of inert ingredients, is available on the FDA website.
Lo/Ovral-28 and generic norgestrel and ethinyl estradiol tablets have been distributed nationwide at warehouses, clinics and retail pharmacies under the Akrimax Pharmaceuticals brand.